Background & aims A recent study showed that serum tumour marker‐based MoRAL score
(11×√ protein induced by vitamin K absence‐II [PIVKA]+ 2×√ alpha‐foetoprotein [AFP]) can …

Background Our study aimed to explore the prognostic value of the aspartate
aminotransferase–platelet ratio index (APRI) and to develop a new nomogram for patients …

Abstract Background/Aims Alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin
(DCP) have been used as diagnostic tools for hepatocellular carcinoma (HCC). However …

In patients with AFP-negative hepatocellular carcinoma (HCC), des-γ-carboxyprothrombin
(DCP) is an important prognostic indicator for the preoperative assessment of transarterial …

547 Background: Causes of variable disease response to first-line treatment with
atezolizumab/bevacizumab (atezo/bev) in hepatocellular carcinoma (HCC) patients remain …

AIMS: To evaluate the clinical inference of serum alpha-fetoprotein (AFP) response in
hepatocellular carcinoma (HCC) patients undergoing percutaneous radiofrequency ablation …

Aim Recurrence of hepatocellular carcinoma (HCC) is observed frequently, even after
curative treatments. The aim of this study is to elucidate the risk factors for recurrence of …

BACKGROUND Alpha-fetoprotein (AFP), a commonly used biomarker for hepatocellular
carcinoma (HCC), is normal in up to one-third of patients. AIM To evaluate the diagnostic …

Background Transcatheter arterial chemoembolization (TACE) is an effective treatment for
hepatocellular carcinoma (HCC), but it sometimes makes liver function worse. The pre …

Background. There have been many reports on des‐γ‐carboxy prothrombin (DCP) as a
promising serum marker in the diagnosis of hepatocellular carcinoma (HCC); however, the …